NCT04596722View on ClinicalTrials.gov

Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

March 24, 2021

Study Completion Date

March 24, 2021

Conditions
Human Microbiome
Interventions
DIETARY_SUPPLEMENT

Pomella

"Pomella® Pomegranate Whole Fruit Extract containing 75 mg punicalagin in white/white HPMC size 1 capsules packed in white color HDPE bottle of 30 counts"

OTHER

Placebo

"White/white HPMC size 1 capsules each containing 97.67% Maltodextrin, 0.10% Tartrazine color, 0.22% Brown Color, 2.01% Aerosil packed in white color HDPE bottle of 30 counts"

Trial Locations (1)

95815

Integrative Skin Science and Research, Sacramento

All Listed Sponsors
collaborator

Verdure Sciences

INDUSTRY

lead

Integrative Skin Science and Research

INDUSTRY

NCT04596722 - Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties | Biotech Hunter | Biotech Hunter